Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bleeding esophageal varices

F L Sax, A M Cooperman

    The Surgical Clinics of North America
    |February 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Current treatments for portal hypertension are disappointing due to progressive liver disease. Shunting operations may worsen liver disease, prompting exploration of alternative nonshunting procedures.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pancreatic cancer: the bigger picture.

    The Surgical clinics of North America·2001
    Same author

    Long-term follow-up of twenty patients with adenocarcinoma of the pancreas: resection following combined modality therapy.

    The Surgical clinics of North America·2001
    Same author

    Computed tomography for pancreatic diseases.

    The Surgical clinics of North America·2001
    Same author

    An overview of pancreatic pseudocysts: the emperor's new clothes revisited.

    The Surgical clinics of North America·2001
    Same author

    Surgical treatment of pancreatic pseudocysts.

    The Surgical clinics of North America·2001
    Same author

    Surgery and chronic pancreatitis.

    The Surgical clinics of North America·2001
    Same journal

    Social Determinants of Health, Health Disparities, and Surgical Equity.

    The Surgical clinics of North America·2026
    Same journal

    Beyond the Scalpel's Reach.

    The Surgical clinics of North America·2026
    Same journal

    Stepwise Solutions-Society.

    The Surgical clinics of North America·2026
    Same journal

    Stepwise Solutions-Hospitals.

    The Surgical clinics of North America·2026
    Same journal

    Stepwise Solutions for Providers.

    The Surgical clinics of North America·2026
    Same journal

    Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

    The Surgical clinics of North America·2026
    See all related articles

    Area of Science:

    • Hepatology
    • Gastroenterology
    • Surgical interventions for liver disease

    Background:

    • Optimal treatment for portal hypertension remains a significant clinical challenge.
    • Existing treatments, particularly shunting operations, are associated with poor outcomes due to progressive liver disease.
    • Dissatisfaction with current shunting procedures has led to consideration of alternative approaches.

    Purpose of the Study:

    • To review the current landscape of portal hypertension treatment.
    • To discuss the limitations of existing shunting operations.
    • To highlight the need for improved patient selection or alternative surgical strategies.

    Main Methods:

    • Review of existing literature on portal hypertension management.
    • Analysis of outcomes associated with shunting versus nonshunting procedures.

    Related Experiment Videos

  • Discussion of emerging interventional techniques.

    • Main Results:

    • Shunting operations may accelerate liver disease progression, leading to suboptimal patient outcomes.
    • Nonshunting operations may increase the risk of recurrent bleeding.
    • Long-term data on splenic artery ligation and embolization are pending.

    Conclusions:

    • There is a critical need to improve patient selection for shunting procedures.
    • Alternative or modified surgical techniques are under investigation for portal hypertension.
    • Further research is required to establish the efficacy of novel treatments.